Biblio

[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is U  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
U
Uckelmann HJ, Armstrong SA. Chromatin Complexes Maintain Self-Renewal of Myeloid Progenitors in AML: Opportunities for Therapeutic Intervention. Stem Cell Reports. 2020.
Uchiyama Y, Yamazaki D, Kobayashi N, Kanda Y, Sugita-Konishi Y. [Electrophysiological Effect of Citreoviridin on Human InducedPluripotent Stem Cell-derived Cardiomyocytes]. Shokuhin Eiseigaku Zasshi. 2022;63(6):210-217.
Uchiyama T, Kawai T, Nakabayashi K, Nakazawa Y, Goto F, Okamura K, Nishimura T, Kato K, Watanabe N, Miura A, et al. Myelodysplasia after clonal hematopoiesis with APOBEC3-mediated CYBB inactivation in retroviral gene therapy for X-CGD. Mol Ther. 2023.
Uchinomiya K, Tomita M. A mathematical model for cancer risk and accumulation of mutations caused by replication errors and external factors. PLoS One. 2023;18(6):e0286499.
Uchino K, Mizuno S, Mizutani M, Horio T, Hanamura I, J Espinoza L, Matsuo K, Onizuka M, Kashiwase K, Morishima Y, et al. Toll-like receptor 1 variation increases the risk of transplant-related mortality in hematologic malignancies. Transpl Immunol. 2016.
Uchino K, Kanasugi J, Enomoto M, Kitamura F, Tsuchida N, Uchiyama Y, Maeda A, Kirino Y, Matsumoto N, Takami A. VEXAS syndrome. Int J Hematol. 2022.
Uchimura K. Single-cell RNA sequencing and kidney organoid differentiation. Clin Exp Nephrol. 2023.
Uchimura R, Ueda T, Fukazawa R, Hayakawa J, Ohashi R, Miura NNagi, Ohno N, Migita M, Itoh Y. Adipose tissue-derived stem cells suppress coronary arteritis of Kawasaki disease in vivo. Pediatr Int. 2019.
Uchimura K, Wu H, Yoshimura Y, Humphreys BD. Human Pluripotent Stem Cell-Derived Kidney Organoids with Improved Collecting Duct Maturation and Injury Modeling. Cell Rep. 2020;33(11):108514.
Uchihara Y, Permata TBunga Maya, Sato H, Kawabata-Iwakawa R, Katada S, Gu W, Kakoti S, Yamauchi M, Kato R, Gondhowiardjo S, et al. DNA damage promotes HLA class I presentation by stimulating a pioneer round of translation-associated antigen production. Mol Cell. 2022.
Uchida K, Urabe K, Naruse K, Mikuni-Takagaki Y, Inoue G, Takaso M. 5. Accelerated Fracture Healing Targeting Periosteal Cells: Possibility of Combined Therapy of Low-Intensity Pulsed Ultrasound (LIPUS), Bone Graft, and Growth Factor (bFGF). J Orthop Trauma. 2016;30(8):S3.
Uchida N, Tasaka M. Regulation of plant vascular stem cells by endodermis-derived EPFL-family peptide hormones and phloem-expressed ERECTA-family receptor kinases. J Exp Bot. 2013.
Uchida T, Doki N, Kishida Y, Nagata A, Yamada Y, Konishi T, Kaito S, Kurosawa S, Yoshifuji K, Shirane S, et al. [Tyrosine kinase inhibitor maintenance therapy following allogenic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia]. Rinsho Ketsueki. 2020;61(1):11-19.
Uchida N, R Weitzel P, Shvygin A, Skala LP, Raines L, Bonifacino AC, Krouse AE, Metzger ME, Donahue RE, Tisdale JF. Total body irradiation must be delivered at high dose for efficient engraftment and tolerance in a rhesus stem cell gene therapy model. Mol Ther Methods Clin Dev. 2016;3:16059.
Uchida N, Hsieh MM, Platner C, Saunthararajah Y, Tisdale JF. Decitabine Suspends Human CD34+ Cell Differentiation and Proliferation during Lentiviral Transduction. PLoS One. 2014;9(8):e104022.
Uchida M, Ishida S, Mochizuki E, Ozawa N, Yonemitsu H, Ochiai H, Nakamura H, Kawashiri T, Kato K, Egashira N, et al. Improvement of Medication Guidance Sheet for Total Body Irradiation/Cyclophosphamide Followed by Allogeneic Hematopoietic Stem Cell Transplantation Based on Real Monitoring Data. Anticancer Res. 2023;43(9):4067-4075.
Uchida S, Hayakawa K, Ogata T, Tanaka S, Kataoka K, Itaka K. Treatment of spinal cord injury by an advanced cell transplantation technology using brain-derived neurotrophic factor-transfected mesenchymal stem cell spheroids. Biomaterials. 2016;109:1-11.
Uchida M, Kato K, Ikesue H, Ichinose K, Hiraiwa H, Sakurai A, Muta T, Takenaka K, Iwasaki H, Miyamoto T, et al. Efficacy and Safety of Aprepitant in Allogeneic Hematopoietic Stem Cell Transplantation. Pharmacotherapy. 2013.
Uchida S, De Gaspari P, Kostin S, Jenniches K, Kilic A, Izumiya Y, Shiojima I, Kreymborg KGrosse, Renz H, Walsh K, et al. Sca1-Derived Cells Are a Source of Myocardial Renewal in the Murine Adult Heart. Stem Cell Reports. 2013;1(5):397-410.
Uccelli A, Laroni A, Ali R, Battaglia MAlberto, Blinkenberg M, Brundin L, Clanet M, Fernandez O, Marriot J, Muraro P, et al. Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial. Lancet Neurol. 2021;20(11):917-929.
Ubogoeva EV, Zemlyanskaya EV, Xu J, Mironova V. Mechanisms of stress response in the root stem cell niche. J Exp Bot. 2021.
Ubil E, Duan J, Pillai ICL, Rosa-Garrido M, Wu Y, Bargiacchi F, Lu Y, Stanbouly S, Huang J, Rojas M, et al. Mesenchymal-endothelial transition contributes to cardiac neovascularization. Nature. 2014.
Ubezio B, Blanco RAgudo, Geudens I, Stanchi F, Mathivet T, Jones ML, Ragab A, Bentley K, Gerhardt H. Synchronization of endothelial Dll4-Notch dynamics switch blood vessels from branching to expansion. Elife. 2016;5.

Pages